Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function

Science

Volumn 275, Issue 5299, 1997, Pages 540-543

  Mittrücker, Hans Willi ^a   Matsuyama, Toshifumi ^b   Grossman, Alex ^a   Kündig, Thomas M ^a   Potter, Julia ^a   Shahinian, Arda ^a   Wakeham, Andrew ^a   Patterson, Bruce ^c   Ohashi, Pamela S ^a   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; HOMEOSTASIS; LYMPHADENOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BONE MARROW CELLS; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; FEMALE; GENE TARGETING; GRAFT VS HOST REACTION; IMMUNIZATION; IMMUNOGLOBULINS; INTERFERON REGULATORY FACTORS; LYMPHATIC DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; MICE, SCID; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTORS;

EID: 15444346834     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5299.540     Document Type: Article

References (31)

1. Here we use the name IRF4, which was suggested and adopted for LSIRF by the nomenclature committee of the Genome Data Base for the gene locus in humans.
2. T. Matsuyama et al., Nucleic Acids Res. 23, 2127 (1995).
3. C. F. Eisenbeis, H. Singh, U. Storb, Genes Dev. 9, 1377 (1995).
4. T. Yamagata et al., Mol. Cel. Biol. 16, 1283 (1996); A. Grossman et al., Genomics 37, 229 (1996).
5. T. Yamagata et al., Mol. Cel. Biol. 16, 1283 (1996); A. Grossman et al., Genomics 37, 229 (1996).
6. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
7. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
8. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
9. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
10. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
11. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
12. M. Lamphier and T. Taniguchi, Immunologist 2, 167 (1994); G. C. Sen and R. M. Ranshoff, Adv. Virus Res. 42, 57 (1993); N. Tanaka et al., Nature 382, 816 (1996); P. S. Vaughan et al., ibid. 377, 362 (1995); N. Tanaka et al., Cell 77, 829 (1994); T. Tamura et al., Nature 376, 596 (1995); R. Kamijo et al. Science 263, 1612 (1994).
13. To construct the targeting vector, an 8.4-kb Hind III fragment containing the promoter and exons 1 to 6 of the IRF4 gene was isolated from a 129J genomic library (1). The neomycin resistance cassette of pKJ1 (neo) [V. L. J. Tybulewicz et al., Cell 65, 1153 (1991)]; a Bam Hi-Hind III fragment containing IRF4 exons 4, 5, and 6 (long arm); and a polymerase chain reaction (PCR) fragment of intron 1 (short arm) were sequentially cloned into pBluescript SK. The targeting vector was linearized, and E14 embryonic stem (ES) cells were transfected and selected with G418. Targeted ES cell colonies were screened by PCR with primers specific for the 3′ region of neo and for a genomic sequence 5′ of the targeting construct. Positive ES cell lines were verified by Southern hybridization after Hind III digestion, with the use of probes specific for a sequence 5′ of the short arm (5′ probe) or for neo. Out of 1500 G418-resistant colonies, we could isolate 8 with the correct mutation and with a single neo integration. Positive ES cells were injected into CD1 blastocysts, and chimeric offspring were mated with C57BL/6 female mice. Mice were screened by Southern blot analysis or by PCR of tail DNA with the primers 5′-GCA ATG GGA AAC TCC GAC AGT-3′ and 5′-CAG CGT CCT CCT CAC GAT TGT-3′, specific for exon 2; and primers 5′-CCG GTG CCC TGA ATG AAC TGC-3′ and 5′-CAA TAT CAC GGG TAG CCA ACG-3′, specific for neo.
14. H.-W. Mittrücker, unpublished observations.
15. R. Carsetti, G. Köhler, M. Lamers, J. Exp. Med. 181, 2129 (1995).
16. To induce the formation of germinal centers, mice were injected intraperitoneally (ip) with sheep red blood cells (1 × 109) in 100 ml of phosphate-buffered saline (PBS) and killed 10 days later. Tissues were fixed in formalin and embedded in paraffin. Sections were stained with hematoxylin-eosin.
17. -/- peritoneal and spleen cells demonstrated no impairment in the processing and presentation of ovalbumin to ovalbumin-specific T cells or of LCMV peptides, after LCMV infection, to LCMV-specific T cells.
18. T. P. Leist, S. P. Cobbold, H. Waldmann, M. Aguet, R. M. Zinkernagel, J. Immunol. 138, 2278 (1987); D. Moskophidis and F. Lehmann-Grube, Proc. Natl. Acad. Sci. U.S.A. 86, 3291 (1989).
19. T. P. Leist, S. P. Cobbold, H. Waldmann, M. Aguet, R. M. Zinkernagel, J. Immunol. 138, 2278 (1987); D. Moskophidis and F. Lehmann-Grube, Proc. Natl. Acad. Sci. U.S.A. 86, 3291 (1989).
20. b and analyzed by flow cytometry.
21. d). Mice (at least five mice per group) were monitored daily and killed when ascites development was visible (17 to 20 days after injection).
22. K. B. Meyer, M. J. Sharpe, M. A. Surani, M. S. Neuberger, Nucleic Acids Res. 18, 5609 (1990); A. G. Betz et al., Cell 77, 239 (1994).
23. K. B. Meyer, M. J. Sharpe, M. A. Surani, M. S. Neuberger, Nucleic Acids Res. 18, 5609 (1990); A. G. Betz et al., Cell 77, 239 (1994).
24. D. M. Willerford et al., Immunity 3, 521 (1995); B. Kneitz, T. Herrmann, S. Yonehara, A. Schimpl, Eur. J. Immunol. 25, 2572 (1996).
25. D. M. Willerford et al., Immunity 3, 521 (1995); B. Kneitz, T. Herrmann, S. Yonehara, A. Schimpl, Eur. J. Immunol. 25, 2572 (1996).
26. A. Shahinian et al., Science 261, 609 (1993); H.-W. Mittrücker et al., J. Exp. Med. 183, 2481 (1996).
27. A. Shahinian et al., Science 261, 609 (1993); H.-W. Mittrücker et al., J. Exp. Med. 183, 2481 (1996).
28. P. Mombaerts et al., Int. Immunol. 6, 1061 (1994).
29. T. Benatar et al., J. Exp. Med. 183, 329 (1996).
30. R. Schmits et al., ibid., p. 1415.
31. Healthy 5-to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann, G. Boehmelt, G. Duncan, D. Ferrick, C. Furlonger, D. Kägi, F. Kiefer, L. Marengere, C. Paige, J. Penninger, M. Saunders, R. Schmits, D. Siderovski, D. Speiser, S. Yoshinaga, and P. Waterhouse for providing reagents and for helpful comments.